Cargando…
Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma
Single-cell technologies have elucidated mechanisms responsible for immune checkpoint inhibitor (ICI) response, but are not amenable to a clinical diagnostic setting. In contrast, bulk RNA sequencing (RNA-seq) is now routine for research and clinical applications. Our workflow uses transcription fac...
Autores principales: | Egan, Donagh, Kreileder, Martina, Nabhan, Myriam, Iglesias-Martinez, Luis F., Dovedi, Simon J., Valge-Archer, Viia, Grover, Amit, Wilkinson, Robert W., Slidel, Timothy, Bendtsen, Claus, Barrett, Ian P., Brennan, Donal J., Kolch, Walter, Zhernovkov, Vadim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398358/ https://www.ncbi.nlm.nih.gov/pubmed/37229623 http://dx.doi.org/10.1158/2326-6066.CIR-22-0563 |
Ejemplares similares
-
Deciphering the tumour immune microenvironment cell by cell
por: Nabhan, M., et al.
Publicado: (2023) -
Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and impact response to immuno-oncology treatments
por: Sitnikova, Suzanne I., et al.
Publicado: (2023) -
A cell-engineered system to assess tumor cell sensitivity to CD8(+) T cell-mediated cytotoxicity
por: Nelson, Nadine, et al.
Publicado: (2019) -
Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation
por: Lopez-Pelaez, Marta, et al.
Publicado: (2022) -
Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control
por: Nakamura, Kyoko, et al.
Publicado: (2021)